Author:
Yang Richard K.,Zhao Pei,Lu Changxue,Luo Jun,Hu Rong
Funder
University of Wisconsin Translational Research Initiatives in Pathology
UW Department of Pathology
Laboratory Medicine
UWCCC
Subject
Pathology and Forensic Medicine
Reference16 articles.
1. Trastuzumab for the treatment of salivary duct carcinoma;Limaye;Oncologist,2013
2. A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer;Falchook;Invest New Drugs,2015
3. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression;Williams;Am J Surg Pathol,2015
4. Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, esistant to androgen-deprivation therapy;Locati;Cancer Biol Ther,2014
5. Clinical activity of androgen-deprivation therapy in patients with metastatic/relapsed androgen receptor–positive salivary gland cancers;Locati;Head Neck,2016
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献